570 — China Traditional Chinese Medicine Holdings Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Market Cap
HK$8.51bn
Enterprise Value
HK$8.51bn
Revenue
CNY14.74bn

Annual income statement for China Traditional Chinese Medicine Holdings Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	HKAS	HKAS	HKAS	HKAS	HKAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	19,053	14,304	18,122	16,510	14,745
Cost of Revenue
Gross Profit	11,829	7,198	9,274	7,856	7,091
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	16,300	13,240	16,695	16,174	15,014
Operating Profit	2,753	1,064	1,427	336	-269
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	2,520	840	1,225	163	-368
Provision for Income Taxes
Net Income After Taxes	2,123	721	1,396	20.8	-458
Minority Interest
Net Income Before Extraordinary Items
Net Income	1,933	764	1,285	54.1	-342
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,933	764	1,285	54.1	-342
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.387	0.182	0.254	0.071	0.028
Dividends per Share
Special Dividends per Share